Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer

MicroRNA profiling of diagnostic needle aspirates from patients with pancreatic cancer

(2012) S Ali et al.   BRITISH JOURNAL OF CANCER

MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma

(2012) Priscilla T.-Y. Law et al.   CARCINOGENESIS

Crizotinib for ALK-Rearranged Non-Small Cell Lung Cancer: A New Targeted Therapy for a New Target

(2012) L. Gandhi et al.   CLINICAL CANCER RESEARCH

Clinical Applications for microRNAs in Cancer

(2012) S P Nana-Sinkam et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy

(2012) Cristina E Tognon et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

(2012) Rafael Rosell et al.   LANCET ONCOLOGY

Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs

(2012) Heidi M. Namløs et al.   PLoS One

MiR-122 Inhibits Cell Proliferation and Tumorigenesis of Breast Cancer by Targeting IGF1R

(2012) Biyun Wang et al.   PLoS One

A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1

(2012) Qing Xu et al.   Journal of Molecular Cell Biology

Diagnosis of lung cancer in individuals with solitary pulmonary nodules by plasma microRNA biomarkers

(2011) Jun Shen et al.   BMC CANCER

The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors

(2011) Giorgio V. Scagliotti et al.   CANCER TREATMENT REVIEWS

A 5-MicroRNA Signature for Lung Squamous Cell Carcinoma Diagnosis and hsa-miR-31 for Prognosis

(2011) X. Tan et al.   CLINICAL CANCER RESEARCH

Genomic Loss of miR-486 Regulates Tumor Progression and the OLFM4 Antiapoptotic Factor in Gastric Cancer

(2011) H.-K. Oh et al.   CLINICAL CANCER RESEARCH

Randomized Phase II Study of Erlotinib in Combination With Placebo or R1507, a Monoclonal Antibody to Insulin-Like Growth Factor-1 Receptor, for Advanced-Stage Non–Small-Cell Lung Cancer

(2011) Suresh S. Ramalingam et al.   JOURNAL OF CLINICAL ONCOLOGY

MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer

(2011) Mattia Boeri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-486-5p Induces Replicative Senescence of Human Adipose Tissue-Derived Mesenchymal Stem Cells and Its Expression Is Controlled by High Glucose

(2011) Yeon Jeong Kim et al.   STEM CELLS AND DEVELOPMENT

MicroRNA profiling reveals that miR-21, miR486 and miR-214 are upregulated and involved in cell survival in Sézary syndrome

(2011) M G Narducci et al.   Cell Death & Disease

Exciting New Targets in Lung Cancer Therapy: ALK, IGF-1R, HDAC, and Hh

(2010) Joel W. Neal et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers

(2010) Lei Yu et al.   INTERNATIONAL JOURNAL OF CANCER

Insulin-like Growth Factor Receptor 1 (IGF1R) Gene Copy Number Is Associated With Survival in Operable Non–Small-Cell Lung Cancer: A Comparison Between IGF1R Fluorescent In Situ Hybridization, Protein Expression, and mRNA Expression

(2010) Rafal Dziadziuszko et al.   JOURNAL OF CLINICAL ONCOLOGY

Serum MicroRNA Signatures Identified in a Genome-Wide Serum MicroRNA Expression Profiling Predict Survival of Non–Small-Cell Lung Cancer

(2010) Zhibin Hu et al.   JOURNAL OF CLINICAL ONCOLOGY

Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486

(2010) E. M. Small et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Safety, Pharmacokinetics, and Pharmacodynamics of the Insulin-Like Growth Factor Type 1 Receptor Inhibitor Figitumumab (CP-751,871) in Combination with Paclitaxel and Carboplatin

(2009) Daniel D. Karp et al.   Journal of Thoracic Oncology

Causes and consequences of microRNA dysregulation in cancer

(2009) Carlo M. Croce   NATURE REVIEWS GENETICS

Novel Rank-Based Statistical Methods Reveal MicroRNAs with Differential Expression in Multiple Cancer Types

(2009) Roy Navon et al.   PLoS One